Dear all****
I attach the current draft of a splicing manuscript based on Geuvadis data.
In case please send me any comments until next *Thursday 21st*
Best wishes
Micha Sammeth
Dear all,
The revised version of the Geuvadis RNAseq main paper has been
resubmitted to Nature. The manuscript files are enclosed for your
reference.
Time to cross fingers again - let's hope for the best!
best regards,
Tuuli
Tuuli Lappalainen, PhD
Department of Genetics, Stanford University School of Medicine , and
Department of Genetic Medicine and Development, University of Geneva
Email: tuuli.e.lappalainen(a)gmail.com / tlappala(a)stanford.edu
Tel: +1 415 351 9713
Bustamante lab
Department of Genetics
300 Pasteur Dr. Lane L301
Stanford, CA 94305-5120
USA
Dear all,
We have revised the Geuvadis RNA-seq paper for Nature; please find the
paper and the response letter enclosed. If you have any comments, please
send them *by Saturday* - apologies for the tight schedule, we are
planning to submit this on Monday. Thanks to all of you who helped me
with the revisions.
As many of you know, the editor adviced us to make the paper more
focused on the key messages, and as a consequence we had to drop some of
the analyses - fusion transcripts, soft splicing and RNA editing. I hope
that those results can be published in some other context later on. To
strengthen the analysis of regulatory variants, I did some additional
analysis on regulatory variants underlying allele-specific expression
signals, but otherwise the changes in the paper are relatively small. I
think that we were able to respond to all the comments really well, and
hopefully the editor and reviewers agree.
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetics, Stanford University School of Medicine , and
Department of Genetic Medicine and Development, University of Geneva
Email: tuuli.e.lappalainen(a)gmail.com / tlappala(a)stanford.edu
Tel: +1 415 351 9713
Bustamante lab
Department of Genetics
300 Pasteur Dr. Lane L301
Stanford, CA 94305-5120
USA
